Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × plerixafor × Sarcoma × Clear all

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Lymphoid 5 Plasma cell 3 Myeloid 2 Gastrointestinal 2 Sarcoma 1 Gynecologic 1 CNS 1

Conditions

Interventions

Temozolomide 54 Cyclophosphamide 54 Radiotherapy 39 Doxorubicin 30 Filgrastim 25 fludarabine 21 Radiation 21 Irinotecan 20 Gemcitabine 20 Magnetic Resonance Spectroscopy 17 Etoposide 17 Imatinib Mesylate 16 Cisplatin 15 Carboplatin 14 Biopsy 14 pembrolizumab 13 fludarabine phosphate 13 Specimen Handling 13 Bevacizumab 13 Granulocyte Colony-Stimulating Factor 12 pazopanib 11 Leucovorin 11 Ifosfamide 11 Vincristine 10 Nivolumab 10 Melphalan 10 Ipilimumab 10 Busulfan 10 Topotecan 9 Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡